A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fed Conditions
Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the rate and extent of absorption of Abrika Bupropion
150 mg Extended-Release Tablet to that of Wellbutrin SR® 150 mg Tablet after a single,
one-tablet dose in subjects fed a standard meal.